Evidence map›Paper›PMID 24982916›Full record

ArticleBioMed research international2014

The effects of omega-3 fatty acid supplementation on dexamethasone-induced muscle atrophy.

Alan Fappi, Tiago S Godoy, Jessica R Maximino, Vanessa R Rizzato, Juliana de C Neves, Gerson Chadi, Edmar Zanoteli

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Antioxidants (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Antioxidants (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Neuraminidase-1 mediates skeletal muscle regeneration.Biochimica et biophysica acta · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alan FappiDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.ORCID 0000-0003-4015-9262
Tiago S GodoyDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.
Jessica R MaximinoDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.
Vanessa R RizzatoDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.
Juliana de C NevesDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.
Gerson ChadiDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.ORCID 0000-0002-9667-0716
Edmar ZanoteliDepartment of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil.ORCID 0000-0002-4991-6760
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosteroids cause muscle atrophy by acting on proteasomal and lysosomal systems and by affecting pathways related to muscular trophysm, such as the IGF-1/PI-3k/Akt/mTOR. Omega-3 fatty acid (n-3) has been used beneficially to attenuate muscle atrophy linked to sepsis and cachexia; however, its effect on dexamethasone-induced muscle atrophy has not been evaluated. Objectives. We evaluated whether n-3 supplementation could mitigate the development of dexamethasone-induced muscle atrophy. Methods. Two groups of Wistar rats were orally supplemented with n-3 or vehicle solution for 40 days. In the last 10 days, dexamethasone, or saline solution, was administrated establishing four groups: control, dexamethasone, n-3, and dexamethasone + n-3. The cross-sectional areas of muscle fibers, gene expression (MyoD, Myogenin, MuRF-1, and Atrogin-1), and protein expression (Akt, GSK3β, FOXO3a, and mTOR) were assessed. Results. Dexamethasone induced a significant loss in body and muscle weight, atrophy in type 2B fibers, and decreased expression of P-Akt, P-GSK3β, and P-FOXO3a. N-3 supplementation did not attenuate the negative effects of dexamethasone on skeletal muscle; instead, it caused atrophy in type 1, 2A, reduced the expression of Myogenin, and increased the expression of Atrogin-1. Conclusion. Food supplements containing n-3 are usually healthful, but they may potentiate some of the side effects of glucocorticoids.

Indexed as

Dietary SupplementsAnimalsChromatography, GasDexamethasoneFatty Acids, Omega-3Forkhead Box Protein O3Forkhead Transcription FactorsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaMaleMuscle Fibers, SkeletalMuscle ProteinsMuscular AtrophyOrgan SizePhosphorylationPolymerase Chain ReactionDexamethasoneFatty Acids, Omega-3Fbxo32 protein, mouseForkhead Box Protein O3Forkhead Transcription FactorsFoxO3 protein, mouseGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseGsk3b protein, ratMuscle ProteinsProto-Oncogene Proteins c-aktSKP Cullin F-Box Protein LigasesTranscription Factors

Identifiers

PMID24982916
PMCPMC4055633
OpenAlexW2146695173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.